Dolobid Side Effects

Common side effects of Dolobid include vomiting, constipation, and nausea. Rare side effects include anemia, depression, and an increase in liver enzymes. Some side effects can be life-threatening. For example, you should call 911 immediately if you experience shortness of breath, slurred speech, or weakness in one part of your body. These side effects can indicate a possible heart attack or stroke.

An Overview of Dolobid Side Effects

As with any medicine, side effects are possible with Dolobid® (diflunisal); but not everyone who takes the drug will have problems. In fact, most people tolerate it quite well. If side effects do occur, in many cases, they are minor, meaning they require no treatment or are easily treated by you or your healthcare provider.
 
Several factors can affect the chances of developing side effects, including:
 
  • Your age
  • Your general health
  • The dose of Dolobid taken
  • Other medical conditions you may have
  • Current medicines you may be currently taking.
     
(This article covers many, but not all, of the possible side effects with Dolobid. Your healthcare provider can discuss a more complete list with you.)
 

Common Side Effects of Dolobid

Dolobid has been studied extensively in clinical trials, with thousands of people having been evaluated.
 In these studies, side effects are always documented and compared to those that occurred in a similar group of people not taking the medicine. This way, it is possible to see what side effects occur, how often they appear, and how they compare to the group not taking the drug.
 
Based on these studies, the most common Dolobid side effects include:
 
Other Dolobid side effects that occur in more than 1 percent of people include but are not limited to:
 
  • Vomiting
  • Constipation
  • Gas
  • Fatigue or tiredness
  • Insomnia
  • Dizziness
  • Ringing in the ears (tinnitus).
     
Dolobid Side Effects Article Continues on Next Page >
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD
Other Articles in This eMedTV Presentation